🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection

Med(2022)10.1016/j.medj.2022.09.010Source: DataRank Database

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection is a research paper published in Med (2022). On theSindex it has a DataRank of 0. It has been cited 42 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access42 citations

Cite:

Linked data & code

cellosaurus gisaid nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (17)IDs (PubMed, PMC)Annotations (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Isabelle Staropoli ORCID,Françoise Porot,Florence Guivel‐Benhassine ORCID,Lynda Handala,Matthieu Prot ORCID

Live enrichment

PubMed:36228619 PMC:PMC9533668

Swiss Vaccine Research Institute

Grant: ANR-10-LABX-77

National Institutes of Health

Grant: U01AI151758

Horizon 2020 Framework Programme

Grant: 653316

Institut Pasteur

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Fondation pour la Recherche Médicale

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9533668

publisherhttps://api.elsevier.com/content/article/PII:S2666634022004111?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666634022004111?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC9533668

Europe_PMChttps://europepmc.org/articles/PMC9533668?pdf=render

MeSH Terms

HumansAntibodies, NeutralizingCOVID-19SARS-CoV-2BNT162 VaccineBreakthrough Infections

Keywords

VariantsVaccineIgGMucosal immunityNeutralizationIGABreakthroughSars-cov-2OmicronTranslation To PatientsBa.5